Back
Arcturus Therapeutics Holdings Vs. ePlus Industry Stock Comparison
Sell
32
ARCT
Arcturus Therapeutics Holdings
Last Price:
18.32
Seasonality Move:
4.49%
Sell
27
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Sell
32
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $19.18. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $19.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.
PLUS Stock Price Chart
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 46.04 | Sell |
| Chaikin Money Flow: | -240644 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.46 - 20.82) | Sell |
| Bollinger Bands (100): | (19.25 - 23.41) | Sell |
PLUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 28.12 | Sell |
| Chaikin Money Flow: | -371573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.15 - 100.85) | Sell |
| Bollinger Bands (100): | (81.19 - 98.29) | Sell |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.99 | Buy |
| 20-day SMA: | 19.26 | Sell |
| 50-day SMA: | 20.58 | Sell |
| 200-day SMA: | 27.29 | Sell |
| 8-day EMA: | 19.22 | Sell |
| 20-day EMA: | 19.5 | Sell |
| 50-day EMA: | 20.49 | Sell |
| 200-day EMA: | 24.49 | Sell |
PLUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.25 | Sell |
| 20-day SMA: | 94.97 | Sell |
| 50-day SMA: | 95.27 | Sell |
| 200-day SMA: | 83.59 | Sell |
| 8-day EMA: | 92.26 | Sell |
| 20-day EMA: | 94.28 | Sell |
| 50-day EMA: | 94.05 | Sell |
| 200-day EMA: | 84.44 | Sell |
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.97 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Arcturus Therapeutics Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ePlus Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||